GSK2018682   Click here for help

GtoPdb Ligand ID: 11311

Synonyms: GSK-2018682
Compound class: Synthetic organic
Comment: GSK2018682 is a S1P1/5 receptor modulator [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 8
Topological polar surface area 103.27
Molecular weight 440.13
XLogP 5.36
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)CCCn1ccc2c1cccc2c1noc(n1)c1cnc(c(c1)Cl)OC(C)C
Isomeric SMILES OC(=O)CCCn1ccc2c1cccc2c1noc(n1)c1cnc(c(c1)Cl)OC(C)C
InChI InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H,28,29)
InChI Key NFIGDBFIDKDNIG-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
GSK2018682 has completed Phase 1 evaluations [1], but has not progressed further.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01387217 GSK2018682 FTIH in Healthy Volunteers Phase 1 Interventional GlaxoSmithKline
NCT01431937 Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers Phase 1 Interventional GlaxoSmithKline